Lasa Supergeneri

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE670X01014
NSEID: LASA
BSEID: 540702
View on NSE | View on BSE

INR

7.68

-0.06 (-0.78%)

BSENSE

Mar 13

BSE+NSE Vol: 82.66 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Veerhealth Care

Murae Organisor

Welcure Drugs

Biofil Chemicals

Roopa Industries

Sandu Pharma.

Vasundhara Rasy.

Vista Pharma.

Lasa Supergeneri

ANG Lifesciences

Vilin Bio Med

Why is Lasa Supergenerics Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -5.16
The company has been able to generate a Return on Equity (avg) of 3.54% signifying low profitability per unit of shareholders funds

Negative results in Dec 25

NET SALES(9M) At Rs 25.27 cr has Grown at -75.54%
PAT(9M) At Rs -9.35 cr has Grown at -75.54%

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -62.55%, its profits have risen by 101.8% ; the PEG ratio of the company is 1.4

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -62.55% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Lasa Supergeneri for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Lasa Supergeneri

-62.55%

-1.00

62.39%

Sensex

1.0%

0.08

12.13%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-21.19%

EBIT Growth (5y)

-180.69%

EBIT to Interest (avg)

-5.16

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.02

Sales to Capital Employed (avg)

1.11

Tax Ratio

16.19%

Dividend Payout Ratio

Pledged Shares

20.66%

Institutional Holding

ROCE (avg)

-0.70%

ROE (avg)

3.54%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

143

Industry P/E

Price to Book Value

0.46

EV to EBIT

-3.81

EV to EBITDA

-21.76

EV to Capital Employed

0.47

EV to Sales

0.62

PEG Ratio

1.40

Dividend Yield

ROCE (Latest)

-7.08%

ROE (Latest)

0.32%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-16What is not working for the Company

NET SALES(Latest six months)

At Rs 5.26 cr has Grown at -92.74%

PAT(Q)

At Rs -2.55 cr has Fallen at -17.3%

Loading Valuation Snapshot...

Here's what is not working for Lasa Supergeneri

Net Sales - Latest six months

At Rs 5.26 cr has Grown at -92.74%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs -2.55 cr has Fallen at -17.3%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)